The 2026 dyslipidemia guideline significantly expanded the U.S. population recommended for primary prevention statin therapy, especially in adults at lower risk.
Postoperative Hypertension Treatment Only Recommended for Symptomatic Inpatients
Using medication to lower asymptomatic postoperative hypertension, a common clinical condition in admitted surgical patients, can have adverse outcomes, so postoperative hypertension should only be treated in inpatient surgical patients when it’s symptomatic, according to a recent review article.
Heart Failure Duration Linked to Cardiac Remodeling, Dysfunction
A new study proposed that pathophysiologic features associated with increased risk in heart failure with preserved ejection fraction (HFpEF) might reflect distinct phenotypes or disease stages related to heart failure (HF) duration and then set out to document that.
Geriatric Surgery Program Enhances Care Coordination, Promotes Safer Surgeries for Older Veterans
A program developed to address the challenges that older adults experience when undergoing surgery has improved the coordination of care for older veterans and promoted safer, more goal-aligned surgery for older adults, according to a recent study.
Survey Found Improved Peritoneal Dialysis Program Infrastructure and Clinical Practices at VHA
Peritoneal dialysis (PD) use among the U.S. veterans is lower than that in the nonveteran kidney failure population. The VA has made access to high quality home dialysis a strategic priority.
New Solutions for an Old Problem: Extending Dopamine Effectiveness in Parkinson’s Disease
Deep brain stimulation works well for some Parkinson’s disease patients for some period of time, but the long-term benefits might not be as promising, according to a new VA study. That brings clinicians back to their problem of decades: How to extend dopamine benefits to avoid “off” episodes. New pharmaceuticals might offer the answers.
More Genetic Testing, New Drug Combinations Hold Promise for Prostate Cancer With Germline Variants
Pathogenic germline variants might be found in a relatively small percentage of prostate cancer patients, but they can make the prognosis much, much worse. Now, the future is looking brighter, with the VA and other healthcare systems spearheading more testing. At the same time, drug combinations involving PARP inhibitors are showing some success in lengthening survival.
For Veterans With Familial Hypercholesterolemia, More Treatment Options Now Available
VA research is helping to change the massive underdiagnosis and undertreatment of familial hypercholesterolemia (FH), using the unparalleled scale of the Million Veteran Program to identify affected veterans and return actionable results. As the treatment landscape expands, including multiple PCSK9 inhibitor option, clinicians now have the tools to bring even severely elevated LDL-C under control.
The Nature of War Is Changing; Medical Care Advances to Meet the Challenges
The DoD hasn’t shared much information, and the news coverage has been spotty, but we now know that, as of May 2026, about 400 U.S. military personnel had been injured in the war with Iran, which began at the end of February. Sadly, 13 died.
Minor Amputation Signals Ongoing Risk for Limb Loss in Veterans With Diabetes and PAD
Veterans with diabetes and peripheral arterial disease (PAD) are at substantial risk for limb loss—even after undergoing procedures that are often considered limb-sparing.
PTSD Symptoms Reduced by Adding Stellate Ganglion Block to CPT
In military personnel and veterans, adding a stellate ganglion block to cognitive processing therapy significantly reduced post-traumatic stress disorder (PTSD) symptoms and helped these individuals recover more quickly, according to a recent study.
Expansion of Trauma Readiness Center Helps Prepare Clinicians for Combat Casualties
The Air Force recently celebrated a significant expansion of its trauma readiness center in Cincinnati. That is where military medical personnel can hone skills they’ll need to treat combat casualties.
Options Multiply for Treating Veterans With Multiple Myeloma
Multiple myeloma (MM) remains treatable but not curable; however, the therapeutic landscape has changed dramatically over the past decade.
Algorithm Aims to Improve Care for Veterans With Hard-to-Treat Epilepsy
Accurate identification of drug-resistant epilepsy (DRE)—a severe form of epilepsy in which seizures continue despite treatment with multiple medications—is essential for improving outcomes. Yet, because DRE is not explicitly coded in medical records, many patients who could benefit from specialized care go unrecognized.
Computerized CBT-Enhanced Collaborative Care Shows Promise for Depression
A new study examined the feasibility, acceptability and potential health effects of computerized cognitive behavioral therapy-enhanced collaborative care (cCBT-CC) vs. usual primary care (UC).
Delays in Care, Medications Can Be Fatal for Veterans With Amyotrophic Lateral Sclerosis
According to veterans with amyotrophic lateral sclerosis (ALS) and their advocates, staffing and budget cuts at VA have created delays in care that could result in fatal complications for someone with the terminal neurodegenerative disorder.
CGM Enhances VA Diabetes Care, but GMI Might Mislead Clinicians
Nearly 1 in 4 veterans receiving care through the VA lives with diabetes—more than twice the prevalence in the general U.S. population—putting them at risk for cardiovascular complications such as stroke, peripheral artery disease and amputations as well as chronic kidney disease, cognitive impairment, diabetic retinopathy and glaucoma, among other conditions.
Caring for the Caregivers: Addressing Vicarious Trauma in Cancer Care
The work performed by healthcare providers at the VA is often tremendously rewarding. Daily interactions with veterans, who have frequently experienced extraordinarily traumatic events, as they go through treatment for serious medical conditions can also be exhausting, however.
Tackling a Killer: New Therapies at the VA vs. Rising Rates of Hepatocellular Carcinoma
Incidence rates for hepatocellular carcinoma (HCC), which accounts for up to 85% of all liver cancers, have tripled since 1980, making it the fastest-growing malignancy by incidence in the U.S.
Epithelial Ovarian Carcinoma Patients Treated at DoD Fare Better Than Those in Community
Patients with epithelial ovarian carcinoma in the DoD Cancer Registry had a better 5-year overall survival compared with a matched sample of U.S. patients from a national database.
AI-Based Radiomic Features Help Predict Benefit, Outcomes in Advanced SCLC
With small cell lung cancer (SCLC), which is aggressive with poor survival outcomes, the majority of patients develop resistance to chemotherapy. Yet, no predictive biomarkers currently guide therapy, according to new research.
System Immunomodulators for Military Skin Conditions
The U.S. military has always had specific guidelines regarding the entry and retention of personnel with eczema and atopic dermatitis.
Data on SCLC Incidence from 2000-2019 Sets Baseline for Post-Immunotherapy Era
From the late 1980s to 2000, small-cell lung cancer (SCLC) made up a decreasing proportion of lung cancer cases in the United States. At the same time, survival outcomes in SCLC did not improve due to few treatment advances.
Hall Helped Develop Frailty Survey to Improve VA Surgery Outcomes
Daniel Hall, MD, MDiv, MHSc, noticed what many surgeons also have over the course of their careers: There was a small number of patients (5-10%) who, despite their surgeries going perfectly, experienced poor outcomes.
New Therapies Offer Options for Veterans With Multiple Myeloma
Past research has suggested a disproportionately high occurrence of multiple myeloma in patients with recorded military services and toxin exposures when compared to control groups.
Veterans Hospitalized for Substance-Use Disorder at High Mortality Risk After Discharge
Past research has revealed that patients who are hospitalized for substance-use disorders appear to have an elevated risk of death, but little information was available on when and why.
Hall Helped Develop Frailty Survey to Improve VA Surgery Outcomes
Daniel Hall, MD, MDiv, MHSc, noticed what many surgeons also have over the course of their careers: There was a small number of patients (5-10%) who, despite their surgeries going perfectly, experienced poor outcomes.
Sudden Cardiac Arrest Survival High in Military, but More Prevention Called For
Sudden cardiac arrest is a silent and often fatal event that strikes without warning, even among those in peak physical condition. In the civilian world, survival rates for out-of-hospital cardiac arrest are alarmingly low.
Aligning Total Joint Arthroplasty Outcomes With Patient Expectations
Patient-reported outcome measures are increasingly integrated into quality assessments following total joint arthroplasty (TJA), but patient perceptions of quality paired with the phase of surgical care has not been described, according to a new report.
Reducing Patient Anxiety Caused by ‘Active Surveillance’ of Low-Risk Cancer
In patients with low-risk cancers undergoing active surveillance, the medical field needs to help manage the anxiety caused by waiting, according to a recent study.